VKTX
$5.72
Viking Thera
($.04)
(.69%)
VKTX
Earnings Whisper ®
N/A
3rd Quarter September 2021
Consensus:  ($0.21)
Revenue:  $0.00 Mil
Wednesday
Nov 3
4:05 PM ET
Score
Grade
Tweet Share Watch
Tweet Share Watch

What do you expect when VKTX reports earnings?
Beat
Meet
Miss

Where is VKTX's stock price going from here?
Up
Flat
Down
Stock chart of VKTX
Analysts
Summary of analysts' recommendations for VKTX
Score
Grade
Pivots
Resistance
$6.00
$5.88
$5.82

$5.70

Support
$5.64
$5.52
$5.46
Tweet
Growth
Description
Viking Therapeutics, Inc. is a biopharmaceutical company. The company is engaged in development of novel therapies for metabolic and endocrine disorders. Its product candidate consists of VK5211, VK0214, VK0612 and VK2809 which are in different clinical trial. Viking Therapeutics, Inc. is based in LA JOLLA, United States.